Autolus reports Q1 2024 Financial Results | Company Announcement

Investegate announcements from Autolus reports Q1 2024 Financial Results

Related Keywords

United Kingdom ,London ,City Of ,United States ,Stevenage ,Hertfordshire ,American ,Susana Noonan ,Johnh Johnson ,Ben Atwell Tim Stamper ,June Dec ,Collins Fergus Witt ,Julia Wilson ,Ravi Rao ,Olivia Manser ,Syncona Ltd ,Nasdaq ,American Society Of Clinical Oncology ,Nature Communications ,University College London ,Exchange Commission ,European Medicines Agency ,European Hematology Association ,Ferrari ,Cardinal Health ,Sa Noonan Communications ,Autolus Therapeutics ,Market Authorization Application ,Syncona Limited ,Therapeutics Reports First Quarter ,Lupus Erythematosus ,Christian Itin ,Chief Executive Officer ,Systemic Lupus Erythematosus ,B Cell Acute Lymphoblastic Leukemia ,Obe Cel Biologics License Application ,American Society ,Clinical Oncology ,Importation Authorization ,Marketing Authorization Application ,Mike Bonney ,Non Executive Director ,Structure Guided Engineering ,Nat Commun ,Blood Cancer Journal ,Dualt Cell ,Blood Cancer ,News Flow ,Quarter Ended March ,Unaudited Condensed Consolidated Statements ,Comprehensive Loss ,Months Ended March ,Private Securities Litigation Reform Act ,Autolu Annual Report ,